Neurogene Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '25 May 14, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	224	340	249	-	-
Market Cap Growth	-73.28%	36.64%	-	-	-
Enterprise Value	-60	214	452	-	-
Last Close Price	15.51	22.86	19.38	-	-
PE Ratio	-	-	18.20	-	-
PS Ratio	239.14	367.11	-	-	-
PB Ratio	0.79	1.09	1.34	-	-
P/TBV Ratio	0.76	1.09	1.34	-	-
EV/Sales Ratio	-	231.03	-	-	-
Debt / Equity Ratio	0.04	0.04	0.08	0.05	0.06
Asset Turnover	0.00	0.00	-	-	-
Quick Ratio	20.80	20.65	8.61	12.48	6.57
Current Ratio	21.03	20.84	8.72	12.74	6.81
Return on Equity (ROE)	-34.97%	-30.28%	-25.52%	-59.77%	-
Return on Assets (ROA)	-21.97%	-18.47%	-20.94%	-33.52%	-
Return on Capital (ROIC)	-22.95%	-19.69%	-22.83%	-36.31%	-
Earnings Yield	-36.56%	-22.13%	-14.61%	-	-
FCF Yield	-32.21%	-21.03%	-20.82%	-	-
Buyback Yield / Dilution	-111.87%	-277.22%	-1080.37%	90.26%	-

Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q